Mr. Janne Kostamo (Executive MBA, M.Sc. in Industrial Eng. and B.Sc. in Mech. Eng.) has been appointed as new CEO of Innokas Medical. 50-year old Kostamo brings 18 years of experience in...
Recent Posts
With their next-generation innovation, Synoste aims to renew surgical treatment related to bone deformities. Innokas Medical is involved in this mission by being one of Synoste's co-creation...
The national Dream Workday is coming again on 2nd October with aim to bring positive energy to the workday and to promote well-being at work. The theme of the day at Innokas is training and...
Innokas Medical and its personnel participated in the Cycling Competition (Kilometrikisa in Finnish), which was a playful contest aiming to enthuse people to cycle more. The Cycling Competition...
Through MDSAP (Medical Device Single Audit) certificate, the companies are able to indicate they operate according to ISO 13485:2016 -standard and regulatory requirements set by Australia, Brazil,...
Innokas Medical and Serres are sponsoring one of the 14 guest rooms of Ronald McDonald House (RMH) Charities in Meilahti, Helsinki. Sponsorship helps covering the costs of operating the House,...
WellO2, innovation developed by the Finnish company WellO2 Oy (formerly known as Hapella Oy), is a breathing exercise device that strengthens and cleanses the lungs. The mission of the company is...
During this weekend, we're celebrating "Juhannus" (a.k.a. Midsummer) here in Finland. For us, it is synonymous with good food, relaxation in saunas and lightning bonfires. It is the time for Finns...
The collaborative consortium has received a significant funding from Business Finland. This two-year Stroke-DATA -project, which is one part of Business Finland’s Smart Life program, is carried...
